| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0054 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |